Osaic Holdings
PRVB

Osaic Holdings’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Osaic Holdings’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,042
Closed -$122K – 7710
2023
Q1 		$122K Sell
5,042
-16,307
-76% -$205K ﹤0.01% 4283
2022
Q4 		$226K Sell
21,349
-85,587
-80% -$691K ﹤0.01% 3744
2022
Q3 		$481K Buy
106,936
+14,850
+16% +$67.7K ﹤0.01% 2928
2022
Q2 		$369K Buy
92,086
+15,590
+20% +$73.9K ﹤0.01% 3233
2022
Q1 		$560K Buy
76,496
+11,043
+17% +$66K ﹤0.01% 3123
2021
Q4 		$368K Sell
65,453
-3,473
-5% -$22.1K ﹤0.01% 3366
2021
Q3 		$441K Buy
68,926
+2,009
+3% +$12.9K ﹤0.01% 3162
2021
Q2 		$564K Buy
66,917
+15,535
+30% +$125K ﹤0.01% 2898
2021
Q1 		$540K Sell
51,382
-1,215
-2% -$17.1K ﹤0.01% 2795
2020
Q4 		$890K Buy
52,597
+457
+0.9% +$6.85K ﹤0.01% 2143
2020
Q3 		$669K Buy
52,140
+35,223
+208% +$445K ﹤0.01% 2167
2020
Q2 		$238K Buy
16,917
+4,867
+40% +$61.4K ﹤0.01% 2970
2020
Q1 		$111K Buy
+12,050
New +$155K ﹤0.01% 3386

Other funds holding PRVB

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Osaic Holdings's PRVB Position: Q2 2023 in Review

Osaic Holdings sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 5,042 shares — an estimated $122K sold.

Osaic Holdings first reported a position in PRVB in Q1 2020 and held it in 13 quarters. The position peaked at $890K in Q4 2020. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • Osaic Holdings reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Osaic Holdings sold 5,042 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $122K.
  • Osaic Holdings first reported a position in Provention Bio, Inc. Common Stock in Q1 2020 and held it in 13 quarters.
  • Osaic Holdings's Provention Bio, Inc. Common Stock position peaked at $890K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.